Opportunity Information: Apply for RFA MH 20 300
The grant opportunity titled "Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-MH-20-300) is a discretionary NIH research grant in the health area (CFDA 93.242) focused on advancing computational and statistical approaches for neuroscience and mental health research. Its central goal is to support projects that either develop new methods or apply cutting-edge existing methods to integrate two major types of genomic information from the brain: bulk or region-level tissue data and single-cell genomic data. By combining these data sources, NIH is aiming to accelerate progress in understanding how specific brain cell types contribute to mental disorders, particularly through identifying cell type-specific gene regulatory networks and the biological pathways that drive disease development (pathogenesis) and disease mechanisms (pathophysiology).
A core theme of the announcement is integration across data scales. Traditional tissue-level genomic assays can capture broad molecular signals across brain regions but often blur together the contributions of many different cell types. Single-cell genomic methods, by contrast, can separate signals by cell type or even cell state but may be limited by sampling, sparsity, batch effects, and other technical issues. This FOA targets computational solutions that can meaningfully connect these complementary perspectives, with the end result being clearer, more mechanistic models of how gene regulation operates within specific neuronal and non-neuronal populations and how those regulatory programs relate to mental illness biology. Projects responsive to the FOA would be expected to produce tools, pipelines, statistical frameworks, or integrative analyses that improve inference about cell type-specific regulation, network structure, and pathway involvement from complex brain genomic datasets.
The mechanism is an R01 research project grant, and clinical trials are not allowed under this announcement, meaning the supported work should be computational, statistical, and/or based on existing or newly generated genomic data rather than interventional studies that prospectively assign human participants to interventions. The opportunity was published by the National Institutes of Health, with an original closing date of September 3, 2019, and a creation date of June 26, 2019. While the award ceiling and expected number of awards are not specified in the provided source fields, applicants would typically shape budgets and timelines to match an R01 scope, emphasizing rigorous methodology, feasibility, and clear deliverables such as software, reproducible workflows, validated models, or high-impact integrative findings.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other entities. In addition, the FOA explicitly highlights further eligible categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISI); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); federally recognized Native American tribal governments and tribal organizations (as well as tribal governments that are not federally recognized); eligible federal agencies; faith-based or community-based organizations; U.S. territories or possessions; regional organizations; and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility reflects an intent to attract strong computational genomics and neuroscience expertise from diverse institutional settings, including international groups and organizations that serve historically underrepresented communities.
In practical terms, a competitive application under this FOA would be expected to clearly define the computational problem in brain genomics integration, explain why existing approaches are insufficient, and propose well-justified methods for integrating tissue-level and single-cell datasets. Strong projects would typically address common challenges in these data such as cell type deconvolution, batch correction, cross-platform harmonization, linking regulatory elements to target genes, network inference, pathway analysis, and validation strategies using independent datasets or orthogonal evidence. The broader scientific payoff NIH is seeking is a more detailed, cell-resolved understanding of molecular circuitry in the brain that can clarify how mental disorders arise and persist, and that can ultimately inform better hypotheses for future experimental work and therapeutic discovery, even though this particular funding announcement is not intended to support clinical trials.Apply for RFA MH 20 300
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2019-06-26.
- Applicants must submit their applications by 2019-09-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed)
Previous opportunity: Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 20 300
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 20 300) also looked into and applied for these:
| Funding Opportunity |
|---|
| NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040 Funding Number: RFA NS 19 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Apply for PAR 19 307 Funding Number: PAR 19 307 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 020 Funding Number: RFA AG 20 020 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Transition to Aging Research for Predoctoral Students (F99/K00) Apply for RFA AG 20 009 Funding Number: RFA AG 20 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 20 021 Funding Number: RFA AG 20 021 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA NS 20 004 Funding Number: RFA NS 20 004 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 19 312 Funding Number: PAR 19 312 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 315 Funding Number: PAR 19 315 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 19 011 Funding Number: RFA RM 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) Apply for PAR 19 311 Funding Number: PAR 19 311 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 19 313 Funding Number: PAR 19 313 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 20 001 Funding Number: RFA AA 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) Apply for RFA AA 20 002 Funding Number: RFA AA 20 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 19 314 Funding Number: PAR 19 314 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Partnerships Initiative (NPI) – Global Health Apply for 7200AA19APS00013 Funding Number: 7200AA19APS00013 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Connecting Kids to Coverage (CKC) HEALTHY KIDS AI/AN Apply for CMS 2D2 20 001 Funding Number: CMS 2D2 20 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $750,000 |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Apply for PAS 19 316 Funding Number: PAS 19 316 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) Apply for PAS 19 317 Funding Number: PAS 19 317 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 20 011 Funding Number: RFA AG 20 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 20 010 Funding Number: RFA AG 20 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 20 300", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
